-
Subject Areas on Research
-
A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection.
-
A Systematic Review of Race and Ethnicity in Hepatitis C Clinical Trial Enrollment.
-
A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design.
-
A flexible statistical model for alignment of label-free proteomics data--incorporating ion mobility and product ion information.
-
A highly sensitive and specific enzyme-linked immunosorbent assay of antibodies to hepatitis C virus.
-
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.
-
A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.
-
A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element.
-
Acquired subretinal flecks secondary to hypovitaminosis A in a patient with hepatitis C.
-
Activation and evasion of antiviral innate immunity by hepatitis C virus.
-
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study.
-
Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review.
-
Altered m6A Modification of Specific Cellular Transcripts Affects Flaviviridae Infection.
-
An Education and Field Experience Program to Increase Detection of Human Immunodeficiency Virus and Hepatitis C Virus.
-
An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.
-
An interrupted time series evaluation of a hepatitis C intervention for persons with HIV.
-
Analysis of site performance in academic-based and community-based centers in the IDEAL Study.
-
Antisense inhibitors, ribozymes, and siRNAs.
-
Ascites in hepatitis C liver transplant recipients frequently occurs in the absence of advanced fibrosis.
-
Association between hepatitis B virus and pancreatic cancer.
-
Association of CYP2B6 Single-Nucleotide Polymorphisms Altering Efavirenz Metabolism With Hepatitis C Virus (HCV) Treatment Relapse Among Human Immunodeficiency Virus/HCV-Coinfected African Americans Receiving Ledipasvir/Sofosbuvir in the ION-4 Trial.
-
Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.
-
Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus.
-
Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico.
-
Case of chronic eosinophilic leukemia with deletion of chromosome 16 and hepatitis C.
-
Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium.
-
Characterization of the emerging HIV type 1 and HCV epidemics among injecting drug users in Dushanbe, Tajikistan.
-
Chronic kidney disease in HIV infection: an urban epidemic.
-
Cirrhosis in hepatitis C virus-infected patients: a review for practitioners new to hepatitis C care.
-
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α-based regimens.
-
Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.
-
Clinical hepatitis after transplantation of hepatitis C virus-positive kidneys: HLA-DR3 as a risk factor for the development of posttransplant hepatitis.
-
Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C.
-
Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication.
-
Combined factor IX and XI deficiency discovered at liver biopsy.
-
Community-based HCV screening: knowledge and attitudes in a high risk urban population.
-
Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.
-
Compliance with referral for hepatitis C evaluation among veterans.
-
Concerted use of immunologic and ultrastructural analyses in diagnostic medicine: immunoelectron microscopy and correlative microscopy.
-
Conjunctival pseudotumor caused by herpes simplex virus infection.
-
Content Validity and Reliability of a Self-Report Measure of Medication Nonadherence in Hepatitis C Treatment.
-
Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0.
-
Convergent evolution of escape from hepaciviral antagonism in primates.
-
Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity.
-
Coordination, Cost, and Changing Epidemiology-Considerations in the Hepatitis C Care Cascade.
-
Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination.
-
Current Management of Hepatitis C Virus Infection.
-
DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinoma.
-
Decreased survival in hepatitis C patients with monomorphic post-transplant lymphoproliferative disorder after liver transplantation treated with frontline immunochemotherapy.
-
Defining the spatial relationship between hepatitis C virus infection and interferon-stimulated gene induction in the human liver.
-
Definition and management of anemia in patients infected with hepatitis C virus.
-
Determining the Incidence of Hepatitis C Virus Infection in Populations: An Important Tool for Epidemic Control.
-
Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy.
-
Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus.
-
Direct acting antivirals for the treatment of hepatitis C in ethnic minority populations.
-
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma.
-
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection: Fulfilling the Potential on the Road to Elimination.
-
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.
-
Direct-Acting Antivirals and Organ Transplantation: Is There Anything We Can't Do?
-
Directly acting antivirals for the treatment of patients with hepatitis C infection: a clinical development update addressing key future challenges.
-
Does this patient with liver disease have cirrhosis?
-
Domino liver transplantation in maple syrup urine disease: a case report and review of the literature.
-
Don't share razors or toothbrushes.
-
Donor-derived hepatitis C in the era of increasing intravenous drug use: A report of the Disease Transmission Advisory Committee.
-
Donor-derived hepatitis C transmission from NAT negative donors-Still an unexpected event!
-
Drug resistance and HCV coinfection in former blood donors infected with HIV type 1 in China.
-
Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
-
Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection.
-
Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection.
-
Effects of a couple-based intervention to reduce risks for HIV, HCV, and STIs among drug-involved heterosexual couples in Kazakhstan: a randomized controlled trial.
-
Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate.
-
Efficacy and safety of simeprevir and sofosbuvir with and without ribavirin in subjects with recurrent genotype 1 hepatitis C postorthotopic liver transplant: the randomized GALAXY study.
-
Efforts at the Frontlines: Implementing a Hepatitis C Testing and Linkage-to-Care Program at the Local Public Health Level.
-
Eight Weeks of Treatment With Glecaprevir/Pibrentasvir Is Safe and Efficacious in an Integrated Analysis of Treatment-Naïve Patients With Hepatitis C Virus Infection.
-
Elevated CD4+/CD25+ T cell frequency and function during acute hepatitis C presage chronic evolution.
-
Elevated serum CA-125 levels: hepatitis or ascites?
-
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
-
Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing.
-
Evaluation for Fibrosis After Cure of Hepatitis C-Reply.
-
Expanding the use of hepatitis C-viremic kidney donors.
-
Facilitating engagement of persons with opioid use disorder in treatment for hepatitis C virus infection via telemedicine: Stories of onsite case managers.
-
Factors influencing the participation of gastroenterologists and hepatologists in clinical research.
-
Frequency and predictors of de novo hepatocellular carcinoma in patients awaiting orthotopic liver transplantation during the model for end-stage liver disease era.
-
Future therapy of hepatitis C.
-
Future trends in managing hepatitis C.
-
GBV-C in HIV-HCV coinfection, low liver-related mortality but high overall mortality.
-
Gender differences in hepatitis C infection and risks among persons with severe mental illness.
-
Genotype 3 Infection: The Last Stand of Hepatitis C Virus.
-
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
-
HCV Positive Allograft Use in Heart Transplant: A Silver Lining to an Epidemic.
-
HIV Prevention Trials Network 078: High Prevalence of Hepatitis C Virus Antibodies Among Urban US Men Who Have Sex With Men, Independent of Human Immunodeficiency Virus Status.
-
HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.
-
HIV risks among injecting and non-injecting female partners of men who inject drugs in Almaty, Kazakhstan: implications for HIV prevention, research, and policy.
-
HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV.
-
Health care utilization in HIV-infected patients: assessing the burden of hepatitis C virus coinfection.
-
Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults.
-
Hepatitis B and C viruses in infants and young children.
-
Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan.
-
Hepatitis C Behind and Beyond Bars: Targeting the US Prison Population and Changing North Carolina Prisoner Health Policy.
-
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
-
Hepatitis C Virus Antibody Screening in a Cohort of Pregnant Women: Identifying Seroprevalence and Risk Factors.
-
Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.
-
Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
-
Hepatitis C Virus Postexposure Prophylaxis in the Healthcare Worker: Why Direct-Acting Antivirals Don't Change a Thing.
-
Hepatitis C Virus Treatment Delivered via Telemedicine to Persons With Opioid Use Disorder.
-
Hepatitis C and the risk of kidney disease and mortality in veterans with HIV.
-
Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.
-
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.
-
Hepatitis C in Patients With Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes.
-
Hepatitis C in Pregnancy: Review of Current Knowledge and Updated Recommendations for Management.
-
Hepatitis C in pregnancy.
-
Hepatitis C infection in children with hemophilia A and B.
-
Hepatitis C transmission, prevention, and treatment knowledge among patients with HIV.
-
Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.
-
Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up.
-
Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival.
-
Hepatitis C-induced hepatic allograft injury is associated with a pretransplantation elevated viral replication rate.
-
Hepatitis C.
-
Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling.
-
High HIV, hepatitis C and sexual risks among drug-using men who have sex with men in northern Thailand.
-
Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis.
-
IFN-free therapy is associated with restoration of type I IFN response in HIV-1 patients with acute HCV infection who achieve SVR.
-
IL28B in the era of direct-acting antivirals for hepatitis C.
-
Identification and comparative analysis of hepatitis C virus-host cell protein interactions.
-
Immunologic Change over 72 Weeks Following Raltegravir- Versus Efavirenz-Based Therapy in HIV/HCV-Coinfected Individuals in Vietnam.
-
Impact of Cigarette Smoking Status on Pain Intensity Among Veterans With and Without Hepatitis C.
-
Impact of donor and recipient hepatitis C status in lung transplantation.
-
Impact of list price changes on out-of-pocket costs and adherence in four high-rebate specialty drugs.
-
Implementation of Pharmacogenetic Testing Within the Veterans Health Administration From 2011 to 2013.
-
Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug-Induced Liver Injury.
-
Improved detection of hepatitis C virus infection by transcription-mediated amplification technology in dialysis population.
-
Improving Access to Hepatitis C Treatment Using Clinical Pharmacist Services in an Uninsured, At-Risk Population at a Community Health Center.
-
Improving HCV Risk Assessment and Testing in a Federally Qualified Health Center Setting in Baltimore, Maryland.
-
Improving Hepatitis C Identification: Technology Alone Is Not the Answer.
-
In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use.
-
In the clinic. Hepatitis C.
-
Index of suspicion.
-
Induction immunosuppression in liver transplantation: a review.
-
Infections during peginterferon/ribavirin therapy are associated with the magnitude of decline in absolute lymphocyte count: results of the IDEAL study.
-
Infectious complications in extended criteria heart transplantation.
-
Innovation, diffusion and safety of a medical technology: a review of the literature on injection practices.
-
Innovations in Heart Transplantation: A Review.
-
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.
-
Insights into antiviral innate immunity revealed by studying hepatitis C virus.
-
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus.
-
Intracellular innate immune cascades and interferon defenses that control hepatitis C virus.
-
Intrahepatic landscape of regulatory T-cell subsets in chronically HCV-infected patients with cirrhosis and HCC.
-
Is the HCV pipeline heading in the right direction?
-
Knowledge of hepatitis C virus screening in long-term pediatric cancer survivors: a report from the Childhood Cancer Survivor Study.
-
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.
-
Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrence.
-
Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades.
-
Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection.
-
Maximizing utilization of the donor pool by appropriate classification of hepatitis C antibody-positive donors.
-
Measuring Hepatitis C Virus Envelopment by Using a Proteinase K Protection Assay.
-
Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals.
-
Membranoproliferative glomerulonephritis type I, mixed cryoglobulinemia and lymphoma in the absence of hepatitis C infection.
-
Meningococcemia in a patient coinfected with hepatitis C virus and HIV.
-
Metabolomic Signature as a Predictor of Liver Disease Events in Patients With HIV/HCV Coinfection.
-
Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
-
Mixed model analysis of censored longitudinal data with flexible random-effects density.
-
Motivations for donating and attitudes toward screening policies in US blood donors with viral infection.
-
Multiinstitutional Evaluation of the Liver Surface Nodularity Score on CT for Staging Liver Fibrosis and Predicting Liver-Related Events in Patients With Hepatitis C.
-
Multinodular focal fatty infiltration of the liver: atypical imaging findings on delayed T1-weighted Gd-BOPTA-enhanced liver-specific MR images.
-
NASH and cryptogenic cirrhosis: a histological analysis.
-
Natural fluctuations of hepatitis C viral load in a homogeneous patient population: a prospective study.
-
New Treatment Options for Hepatitis C Virus Infection in End-Stage Kidney Disease: To Treat or Not to Treat.
-
Non-A, non-B hepatitis and chronic dialysis--another dilemma.
-
Non-Hodgkin's lymphomas, version 1.2013.
-
Nonalcoholic Fatty Liver Disease Risk Factors Affect Liver-Related Outcomes After Direct-Acting Antiviral Treatment for Hepatitis C.
-
Nontargeted Hepatitis C Screening in an Urban Emergency Department in New York City.
-
Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs.
-
Overcoming barriers to care for hepatitis C.
-
Patient-care practices associated with an increased prevalence of hepatitis C virus infection among chronic hemodialysis patients.
-
Patient-centered HCV care via telemedicine for individuals on medication for opioid use disorder: Telemedicine for Evaluation, Adherence and Medication for Hepatitis C (TEAM-C).
-
Patient-reported outcomes 12 months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP study.
-
Peginterferon alpha-2b: a new approach to improving response in hepatitis C patients.
-
Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America.
-
Predictors of proteinuria and renal failure among women with HIV infection.
-
Pregnancy outcomes associated with viral hepatitis.
-
Premature Rupture of Membranes with Concurrent Viral Infection.
-
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.
-
Prevalence of non-A,non-B hepatitis/hepatitis C virus antibody in human immunoglobulins.
-
Prolonged rewarming time during allograft implantation predisposes to recurrent hepatitis C infection after liver transplantation.
-
Proton pump inhibitor usage reduces sustained viral response rates for veterans with HIV/HCV coinfection on ledipasvir/sofosbuvir: a real-world study from a multicentre VA cohort.
-
Providing primary care for long-term survivors of childhood acute lymphoblastic leukemia.
-
Pure red cell aplasia following pegylated interferon alpha treatment.
-
Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans with severe mental illness.
-
Racial differences in hepatitis C treatment eligibility.
-
Real-World Effectiveness of DAA Therapies in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection: 996 Veterans Can't Be Wrong.
-
Recurrent demyelinating myelitis associated with hepatitis C viral infection.
-
Regular sources of medical care among persons with severe mental illness at risk of hepatitis C infection.
-
Regulation of hepatic innate immunity by hepatitis C virus.
-
Reply to: "Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)".
-
Results of a pilot test of a brief computer-assisted tailored HIV prevention intervention for use with a range of demographic and risk groups.
-
Risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness.
-
Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus.
-
Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
-
Risk factors for retrovirus and hepatitis virus infections in accepted blood donors.
-
Risks of a range of alcohol intake on hepatitis C-related fibrosis.
-
Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication.
-
Safety of 2 months of rifampin and pyrazinamide for treatment of latent tuberculosis.
-
Secondary immunodeficiencies and stem cell transplantation: issues of administration and safety of intravenous immunoglobulin.
-
Seroconversion for hepatitis C virus antibody in bone marrow recipients treated with immune globulin.
-
Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma.
-
Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection.
-
Shifting Away From Fee-For-Service: Alternative Approaches to Payment in Gastroenterology.
-
Short and Long-Term Postoperative Complications Following Total Joint Arthroplasty in Patients With Human Immunodeficiency Virus, Hepatitis B, or Hepatitis C.
-
Silent damage? Occult HCV replication and histological disease may occur following apparent HCV clearance.
-
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.
-
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.
-
Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection.
-
Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
-
Staphylococcus aureus pericardial abscess in a patient with liver cirrhosis: case report.
-
Statin Utilization and Recommendations Among HIV- and HCV-infected Veterans: A Cohort Study.
-
Streptococcus equi primary bacteremia in a hepatitis-C cirrhotic patient.
-
Substance abuse and the transmission of hepatitis C among persons with severe mental illness.
-
Successes and Challenges on the Road to Cure Hepatitis C.
-
Surveillance for hepatocellular carcinoma.
-
Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan.
-
Sustainable and equivalent improvements in symptoms and functional well-being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trial.
-
Syringe Decriminalization Advocacy in Red States: Lessons from the North Carolina Harm Reduction Coalition.
-
Syringe exchanges: a public health response to problem drug use.
-
Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus - CDC Guidance, United States, 2020.
-
The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year.
-
The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.
-
The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States.
-
The association of hepatitis C infection with the onset of CKD and progression into ESRD.
-
The face of future hepatitis C antiviral drug development: recent biological and virologic advances and their translation to drug development and clinical practice.
-
The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs.
-
The five-site health and risk study of blood-borne infections among persons with severe mental illness.
-
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
-
The hepatitis C crisis in the African American Community: findings and recommendations.
-
The impact of HCV therapy in a high HIV-HCV prevalence population: A modeling study on people who inject drugs in Ho Chi Minh City, Vietnam.
-
The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
-
The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis.
-
The increasing impact of human immunodeficiency virus infections, sexually transmitted diseases, and viral hepatitis in Durham County, North Carolina: a call for coordinated and integrated services.
-
The natural history of hepatitis C viral infection.
-
Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling.
-
Transplant Outcomes in Older Patients With Nonalcoholic Steatohepatitis Compared to Alcohol-related Liver Disease and Hepatitis C.
-
Treatment of acute hepatitis C infection: more pieces of the puzzle?
-
Treatment of acute hepatitis C with interferon alfa-2b.
-
Treatment of hepatitis C in special populations.
-
Two Cases and a Review of Graft-Versus-Host Disease and the Role of Hepatitis C Treatment in Liver Transplant Patients.
-
Ultrasound guided biopsy: what's new?
-
Undetectable Hepatitis C Viral Load Is Associated With Improved Outcomes Following Total Joint Arthroplasty.
-
Using Stepwise Pharmacogenomics and Proteomics to Predict Hepatitis C Treatment Response in Difficult to Treat Patient Populations.
-
Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement.
-
WTAP Targets the METTL3 m6A-Methyltransferase Complex to Cytoplasmic Hepatitis C Virus RNA to Regulate Infection.
-
Keywords of People
-
-
Horner, Stacy M.,
Associate Professor in Immunology,
Duke Science & Society
-
Knechtle, Stuart Johnston,
William R. Kenan, Jr. Distinguished Professor,
Medicine, Nephrology
-
Milano, Carmelo Alessio,
Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery,
Surgery, Cardiovascular and Thoracic Surgery
-
Muir, Andrew Joseph,
Professor of Medicine,
Duke Innovation & Entrepreneurship
-
Tsalik, Ephraim,
Adjunct Associate Professor in the Department of Medicine,
Medicine, Infectious Diseases
-
Wu, Li-Tzy,
Professor in Psychiatry and Behavioral Sciences,
Medicine, General Internal Medicine